Rivipansel Completed Phase 2 Trials for Sickle Cell Disease (SCD) / Pain Crisis / Vaso-occlusive Crisis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01119833Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis